Sydney’s Bankstown Hospital joins global study to treat Crohn’s disease

Sydney’s Bankstown Hospital has announced that it had participated in a global trial of a drug that is used to Crohn’s disease, in a move that is expected benefit thousands of Australians suffering from the condition. Available figures suggest that as many as 40,000 people in Australia are affected with Crohn’s disease, which can be described as an inflammatory bowel condition. Crohn’s disease poses risk to the small intestine, causing stomach pain with a range of symptoms such as weight loss and fever.

The condition ranges in seriousness from just making the sufferer to go to the bathroom several times to major intensive surgery. Dana Bernstein, 22, who has been suffering from the condition since the age of three, said, “It affects every second and every minute of an everyday life. People have no idea. We can look great on the outside, but we can be in the hospital within a matter of hours.” Meanwhile, researchers at Tel Aviv, Israel-based Chaim Sheba Medical Center, studied the efficacy of inhaled prescription cannabis in patients suffering from conditions like Crohn’s disease, and found that found the patients reporting improvement in quality of life measurements.

via :

VN:F [1.9.22_1171]
Rating: 10.0/10 (3 votes cast)
VN:F [1.9.22_1171]
Rating: +2 (from 2 votes)
Sydney's Bankstown Hospital joins global study to treat Crohn's disease, 10.0 out of 10 based on 3 ratings

Leave a Reply

You must be logged in to post a comment.